PNCA5
MCID: PNC132
MIFTS: 23

Pancreatic Cancer 5 (PNCA5)

Categories: Cancer diseases, Endocrine diseases, Gastrointestinal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Pancreatic Cancer 5

MalaCards integrated aliases for Pancreatic Cancer 5:

Name: Pancreatic Cancer 5 56
Pancreatic Cancer, Susceptibility to, 5 56 6
Pnca5 56

Classifications:



External Ids:

OMIM 56 618680

Summaries for Pancreatic Cancer 5

OMIM : 56 Susceptibility to pancreatic ductal adenocarcinoma (PDAC) may be conferred by mutation in RABL3. Other cancers, including melanoma, breast cancer, and colon cancer, have been reported in RABL3 mutation-carrying individuals, with or without PDAC (Nissim et al., 2019). For background, phenotypic description, and a discussion of genetic heterogeneity of pancreatic carcinoma, see 260350. (618680)

MalaCards based summary : Pancreatic Cancer 5, also known as pancreatic cancer, susceptibility to, 5, is related to pancreatic cancer and pancreatic ductal adenocarcinoma. An important gene associated with Pancreatic Cancer 5 is RABL3 (RAB, Member Of RAS Oncogene Family Like 3). The drugs Capecitabine and Pancrelipase have been mentioned in the context of this disorder. Affiliated tissues include colon, breast and pancreas.

Related Diseases for Pancreatic Cancer 5

Diseases in the Pancreatic Cancer family:

Pancreatic Cancer 1 Pancreatic Cancer 2
Pancreatic Cancer 3 Pancreatic Cancer 4
Pancreatic Cancer 5

Diseases related to Pancreatic Cancer 5 via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 pancreatic cancer 9.9
2 pancreatic ductal adenocarcinoma 9.8
3 giant cell tumor 9.4 PLAUR CSF1
4 pancreatic adenocarcinoma 9.3 PLAUR CSF1
5 acute promyelocytic leukemia 9.2 PLAUR CSF1

Graphical network of the top 20 diseases related to Pancreatic Cancer 5:



Diseases related to Pancreatic Cancer 5

Symptoms & Phenotypes for Pancreatic Cancer 5

Clinical features from OMIM:

618680

Drugs & Therapeutics for Pancreatic Cancer 5

Drugs for Pancreatic Cancer 5 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 7)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Capecitabine Approved, Investigational Phase 3 154361-50-9 60953
2
Pancrelipase Approved, Investigational Phase 3 53608-75-6
3 Antimetabolites Phase 3
4 pancreatin Phase 3
5
s 1 (combination) Phase 2
6 Vaccines Phase 2
7 Immunologic Factors Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 A Randomized, Double-Blind, Phase 3 Study of the JAK 1/2 Inhibitor Ruxolitinib or Placebo in Combination With Capecitabine in Subjects With Advanced or Metastatic Adenocarcinoma of the Pancreas Who Have Failed or Are Intolerant to First-Line Chemotherapy (The JANUS 2 Study) Terminated NCT02119663 Phase 3 Ruxolitinib;Placebo;Capecitabine
2 The Safety and Efficacy of Combination of Stereotactic Body Radiation Therapy With S-1 in Treating Locally Advanced Pancreatic cancer--a Phase II Clinical Trial Unknown status NCT02704143 Phase 2
3 A Phase II Study of Apoptosis Induction Through Direct Tumor Injection of TNFerade(TM)or Radiation Alone Followed by KLH-Pulsed Autologous Dendritic Cells in Patients With Unresectable Pancreatic Cancer Terminated NCT00868114 Phase 2
4 The Clinical Utility of a Blood-Based Multitranscriptome Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors Active, not recruiting NCT02948946
5 Tight Caloric Control in the Cachectic Oncologic Patient (TiCaCONCO or CoCooN) Can Stabilize Body Weight, Thereby Reducing Morbidity and Mortality: Validation of the Pilot Study - A Randomized Controlled Double-Blind Trial Active, not recruiting NCT03058107

Search NIH Clinical Center for Pancreatic Cancer 5

Genetic Tests for Pancreatic Cancer 5

Anatomical Context for Pancreatic Cancer 5

MalaCards organs/tissues related to Pancreatic Cancer 5:

40
Colon, Breast, Pancreas, Lung

Publications for Pancreatic Cancer 5

Articles related to Pancreatic Cancer 5:

(show all 26)
# Title Authors PMID Year
1
Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer. 56 6
31406347 2019
2
Clinical Limitations of Photon, Proton and Carbon Ion Therapy for Pancreatic Cancer. 61
31936565 2020
3
Noncutaneous and Cutaneous Cancer Risk in Patients With Atopic Dermatitis: A Systematic Review and Meta-analysis. 61
31825457 2019
4
Factors Associated with Malignant Biliary Strictures in Patients with Atypical or Suspicious Cells on Brush Cytology. 61
30625267 2019
5
[The effect of circulating tumor cells on the survival of patients with pancreatic cancer 5-year results]. 61
29444581 2018
6
Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study. 61
27604035 2017
7
Pancreatic Cancer Genetics. 61
26929738 2016
8
[Surgical therapy of pancreatic cancer - 5 years survival]. 61
26766155 2015
9
Patients with obstructive jaundice and biliary stricture ± mass lesion on imaging: prevalence of malignancy and potential role of EUS-FNA. 61
23340062 2013
10
[The evaluation of mortality in abdominal surgery of patients aged over 75. A retrospective study on a series of 111 cases]. 61
22276460 2011
11
Perioperative intra-arterial and systemic chemotherapy for pancreatic cancer. 61
21046268 2011
12
Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. 61
19826273 2010
13
Identification of a novel antibody associated with autoimmune pancreatitis. 61
19940298 2009
14
Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas. 61
19720778 2009
15
Role of ASC in hypoxia-mediated cell death in pancreatic cancer. 61
21479491 2008
16
Interaction between capecitabine and gemcitabine with warfarin in a patient with pancreatic cancer. 61
18981557 2008
17
Docetaxel as salvage therapy in highly pretreated and drug resistant gastrointestinal carcinomas. 61
21892332 2008
18
The agreement between measured and predicted resting energy expenditure in patients with pancreatic cancer: a pilot study. 61
14730120 2004
19
Nutritional links to plausible mechanisms underlying pancreatic cancer: a conference report. 61
14576500 2003
20
Advanced pancreatic cancer--5 years on. 61
12181237 2002
21
Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study. 61
10487547 1999
22
Study of the expression of the gene encoding Ki-67 antigen in human pancreatic cancer using non-radioactive in situ hybridization and immunohistochemistry. 61
9772421 1997
23
[Conservative treatment of complete distal pancreatic fistula]. 61
9297021 1997
24
[Chemotherapy for pancreatic cancer]. 61
8886035 1996
25
Production of monoclonal antibodies to serum antigens in colorectal carcinoma. 61
3286775 1988
26
Grey-scale ultrasonography in cholestatic jaundice. 61
761837 1979

Variations for Pancreatic Cancer 5

ClinVar genetic disease variations for Pancreatic Cancer 5:

6 ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 RABL3 NM_173825.5(RABL3):c.107C>A (p.Ser36Ter)SNV risk factor 694664 3:120449574-120449574 3:120730727-120730727

Expression for Pancreatic Cancer 5

Search GEO for disease gene expression data for Pancreatic Cancer 5.

Pathways for Pancreatic Cancer 5

GO Terms for Pancreatic Cancer 5

Cellular components related to Pancreatic Cancer 5 according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 endoplasmic reticulum lumen GO:0005788 8.62 PLAUR CSF1

Sources for Pancreatic Cancer 5

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....